Supraglottic Airway Devices in Obese Patients

Introduction: Obesity presents significant challenges in airway management due to reduced respiratory reserve, increased oxygen consumption, and a higher risk of airway complications.

Background: Supraglottic airway devices are increasingly used in obese patients as an alternative to endotracheal intubation during general anaesthesia.

Study Objective: To compare the efficacy and safety of different supraglottic airway devices in patients with obesity.

Airway Management: Evaluate the ease of insertion, insertion time, and success rate of different supraglottic airway devices.

Ventilation Performance: Assess ventilation quality, airway seal pressure, oxygenation, and adequacy of ventilation.

Patient Safety: Compare complications such as airway obstruction, gastric insufflation, regurgitation, and aspiration.

Haemodynamic Responses: Evaluate changes in heart rate and blood pressure associated with device insertion and removal.

Postoperative Outcomes: Assess postoperative sore throat, coughing, hoarseness, and other airway-related complications.

Conclusion: Identifying the most effective and safe supraglottic airway device can improve airway management and perioperative outcomes in patients with obesity.